Dose ranging, expanded acute toxicity and safety pharmacology studies for intravenously administered functionalized graphene nanoparticle formulations
about
Carbon Nanomaterials Interfacing with Neurons: An In vivo PerspectiveTight junction between endothelial cells: the interaction between nanoparticles and blood vesselsInteraction of graphene nanoribbons with components of the blood vascular systemToxicology of graphene-based nanomaterialsReduced graphene oxide: nanotoxicological profile in ratsLong Term Influence of Carbon Nanoparticles on Health and Liver Status in RatsToxicology of chemically modified graphene-based materials for medical application.Renal interstitial fibrosis induced by high-dose mesoporous silica nanoparticles via the NF-κB signaling pathway.Reduced graphene oxide induces transient blood-brain barrier opening: an in vivo study.Towards An Advanced Graphene-Based Magnetic Resonance Imaging Contrast Agent: Sub-acute Toxicity and Efficacy Studies in Small Animals.Graphene-based platforms for cancer therapeuticsMetabolomics techniques for nanotoxicity investigations.The Molecular Influence of Graphene and Graphene Oxide on the Immune System Under In Vitro and In Vivo Conditions.Structural disruption increases toxicity of graphene nanoribbons.Two-Dimensional Nanomaterials for Cancer Nanotheranostics.Preclinical safety assessments of nano-sized constructs on cardiovascular system toxicity: A case for telemetry.Bioaccumulation and Toxicity of Carbon Nanoparticles Suspension Injection in Intravenously Exposed Mice.Mechanism of graphene-induced cytotoxicity: Role of endonucleases.Interfacing Graphene-Based Materials With Neural Cells.In vivo toxicological evaluation of graphene oxide nanoplatelets for clinical application
P2860
Q26745423-92665394-1E32-49D9-8CEE-F8C322401DE6Q26747571-A9AD8C10-BFDB-4E11-BE76-C64C4D4CF465Q28387840-8DD8A12B-9DBC-4995-A958-CE123B0E1D51Q28390234-8BC8C77B-4240-4471-BF82-A0493B1E235AQ28397776-CD6497F4-F92E-4DBE-B3C8-7C6C96EAA46DQ28551503-EE6BA251-75D2-4DBF-9F11-51B6F65137F4Q30427860-AA1A9E69-2584-4F2F-B88E-E9671770F7DAQ34763969-E4FF9A75-7803-403A-AC59-30D21DCB6972Q35827779-CFACA0CF-C3D8-4777-9FA0-A5477F50C3B2Q36340346-94050FB8-0012-4F1B-9E85-4E858CE3E1BAQ37158662-2604B87E-35FF-4B16-9E65-9E5ADD1647BCQ38546017-818948D4-4AB2-4D93-AF43-7BFE56B706D8Q38616577-9320A7C1-A7D6-461D-BABE-E3A9EBCCE93EQ38956238-1FBDFF3D-D56A-47B8-A39B-98EFA2535F9BQ39079409-7FDFC346-76CF-4438-A2EF-9DF8FA6D3289Q39121977-91623D8F-73E2-48DA-9C5F-44DAA765AD89Q47303077-160CAC1F-D8F6-4E43-A366-E4803CC1D80DQ47876525-8C9BB271-47C8-4029-AD2E-26C18F35BF4CQ52562684-6C9F3A92-C273-4078-9B72-F93E558B6F92Q57134755-7E6A0E2C-B206-4812-BA29-C1D1AEB4F307
P2860
Dose ranging, expanded acute toxicity and safety pharmacology studies for intravenously administered functionalized graphene nanoparticle formulations
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Dose ranging, expanded acute t ...... hene nanoparticle formulations
@ast
Dose ranging, expanded acute t ...... hene nanoparticle formulations
@en
type
label
Dose ranging, expanded acute t ...... hene nanoparticle formulations
@ast
Dose ranging, expanded acute t ...... hene nanoparticle formulations
@en
prefLabel
Dose ranging, expanded acute t ...... hene nanoparticle formulations
@ast
Dose ranging, expanded acute t ...... hene nanoparticle formulations
@en
P2093
P2860
P921
P1433
P1476
Dose ranging, expanded acute t ...... hene nanoparticle formulations
@en
P2093
Balaji Sitharaman
Jimmy D Toussaint
Kenneth R Shroyer
Richard Z Lin
Sayan Mullick Chowdhury
Shruti Kanakia
Stephen Lee
Tanuf Tembulkar
William Moore
Ya-Ping Jiang
P2860
P304
P356
10.1016/J.BIOMATERIALS.2014.04.066
P577
2014-05-20T00:00:00Z